Product information

From Health Canada

New search

Current status:

Marketed

Current status date:

2021-03-29

Original market date: See footnote 1

2021-03-29

Product name:

APO-SAXAGLIPTIN

DIN:

02507498 Electronic product monograph is not available

Company: 

APOTEX INC
150 Signet Drive
Toronto
Ontario
Canada  M9L 1T9

Class: 

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

68:20.05   DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS

Anatomical Therapeutic Chemical (ATC): See footnote 4

A10BH03  SAXAGLIPTIN

Active ingredient group (AIG) number:See footnote 5

0152653001

List of active ingredient(s)
Active ingredient(s) Strength
SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) 5 MG

Application information

Related information

Contact us

Version 3.8.0
Date modified: